
Loading, please wait...

Loading, please wait...

Scientists recently published a major study in JAMA examining colorectal cancer risk among older adults. This research specifically focuses on patients aged 75 and older who have a history of adenoma on prior colonoscopies. Current guidelines often recommend against routine screening in those without prior findings. However, the risk for those with a history of adenoma remained unclear until now. This study provides critical data to help clinicians weigh the benefits and risks of continuing surveillance in the elderly population.
Researchers analyzed a large cohort of over 91,000 veterans to understand these trends. They compared the 10-year incidence of cancer and mortality between individuals with and without a history of adenoma. For instance, the cumulative 10-year incidence of CRC was 1.1% for those with prior adenoma. In contrast, it was only 0.7% for those without adenoma findings. Although the history of polyps increases the statistical risk, the absolute difference remains remarkably small for most patients.
A significant finding of this study is the high rate of non-cancer-related mortality among older adults. Moreover, frailty plays a decisive role in determining these clinical outcomes. In non-frail patients with adenoma, the 10-year non-CRC death rate was approximately 19.3%. Consequently, this rate surged to 93.3% among those categorized with severe frailty. These results suggest that most older adults are far more likely to die from other health conditions than from colorectal cancer risk. Therefore, clinicians should prioritize a patient's overall health status and estimated life expectancy when discussing further screening.
Specifically, for those with high frailty scores, the potential harms of colonoscopy likely outweigh the benefits of cancer detection. Additionally, doctors should engage in shared decision-making with their patients. This approach focuses on individualized risk rather than chronological age alone. Furthermore, prioritizing geriatric assessments can prevent unnecessary and invasive procedures in vulnerable patients.
While the risk of cancer is slightly higher in those with prior adenomas (1.1% vs 0.7%), the decision to repeat a colonoscopy should depend on the patient's overall health and life expectancy, as non-cancer mortality is often significantly higher.
Frailty is a major predictor of mortality from other causes. For severely frail patients, the chance of dying from non-cancer causes within 10 years is over 90%, making the benefits of cancer screening minimal compared to the procedural risks.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship between you and any healthcare provider. The information provided is based on specific research and should be interpreted within the context of individual patient needs. Refer to the latest local and national guidelines for clinical practice.
References
1. Gupta S et al. Colorectal Cancer and Mortality Risk Among Older Adults With vs Without Adenoma on Prior Colonoscopy. JAMA. 2026 Apr 09. doi: 10.1001/jama.2026.3414. PMID: 41954928.
2. Indian Council of Medical Research (ICMR). Consensus Document for Management of Colorectal Cancer. 2022.
3. U.S. Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A retrospective study highlights that non-CRC mortality often exceeds colorectal cancer risk in older adults, emphasizing the need for frailty-based screeni...
6 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today

A randomized controlled trial demonstrates that an eight-week dual-task training intervention significantly improves static and dynamic postural control over standard balance exercises in individuals with chronic ankle instability, addressing critical neurocognitive deficits during athletic and daily activities.
Today

A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today